Genetic variants in the RAS pathway have recently been implicated in the onset and severity of ARDS, specifically angiotensin-converting enzyme (ACE), and its derivatives (Imai et al., 2010). The gene discussed is ACE; the disease is acute respiratory distress syndrome.